Withanolide A

CAS No. 32911-62-9

Withanolide A ( —— )

Catalog No. M24266 CAS No. 32911-62-9

Withanolide A extends the lifespan in human EGFR-driven cancerous Caenorhabditis elegans.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 335 In Stock
10MG 500 In Stock
25MG 806 In Stock
50MG 1098 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Withanolide A
  • Note
    Research use only, not for human use.
  • Brief Description
    Withanolide A extends the lifespan in human EGFR-driven cancerous Caenorhabditis elegans.
  • Description
    Withanolide A extends the lifespan in human EGFR-driven cancerous Caenorhabditis elegans.
  • Synonyms
    ——
  • Pathway
    Angiogenesis
  • Target
    EGFR
  • Recptor
    EGFR;NF-κB;TNF-α
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    32911-62-9
  • Formula Weight
    470.6
  • Molecular Formula
    C28H38O6
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=C1O[C@@]([H])([C@@](C)([C@H]2CC[C@]3([C@@]4([C@H]5[C@@H]([C@@](O)(CC=CC6=O)[C@]6([C@]4(CC[C@@]32C)[H])C)O5)[H])[H])O)CC(C)=C1C
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Molecular docking, QSAR and ADMET studies of withanolide analogs against breast cancer.Drug Des Devel Ther. 2017 Jun 22;11:1859-1870.
molnova catalog
related products
  • Desmethyl Erlotinib

    OSI-420 is the active metabolite of Erlotinib (EGFR inhibitor with IC50 of 2 nM).

  • Epertinib

    Epertinib (S-222611) is a novel potent, orally active, reversible EGFR and HER2 inhibitor with IC50 of 1.48, 7.15 and 2.49 nM for EGFR, HER2 and HER4, respectively.

  • Lifirafenib

    Lifirafenib is a potent inhibitor of RAF family kinases and EGFR in biochemical assays with IC50 of 23, 29 and 495 nM for the recombinant BRAFV600E kinase domain, EGFR and EGFR T790M/L858R mutant respectively.